Krystal Biotech, Inc. (KRYS)
266.04
+3.78
(+1.44%)
USD |
NASDAQ |
May 01, 16:00
266.24
+0.20
(+0.08%)
After-Hours: 20:00
Krystal Biotech EPS Diluted (Quarterly) : 1.699 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Scholar Rock Holding Corp. | -0.8824 |
| Stoke Therapeutics, Inc. | -0.9922 |
| Moderna, Inc. | -2.107 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| TG Therapeutics, Inc. | 0.1446 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 51.40M |
| Revenue (Quarterly) | 107.10M |
| Total Expenses (Quarterly) | 55.70M |
| Enterprise Value | 7.013B |
| Gross Profit Margin (Quarterly) | 92.39% |
| Profit Margin (Quarterly) | 47.99% |
| Earnings Yield | 2.57% |
| Operating Earnings Yield | 2.02% |
| Normalized Earnings Yield | 2.573 |